Literature DB >> 7853867

Cryptolepis sanguinolenta activity against diarrhoeal bacteria.

A Paulo1, M Pimentel, S Viegas, I Pires, A Duarte, J Cabrita, E T Gomes.   

Abstract

Cryptolepine is the main alkaloid of Cryptolepis sanguinolenta (Lindl.) Schlechter, a plant used in traditional medicine in West Africa. The minimal inhibitory concentrations (MICs) of cryptolepine, ethanol and aqueous extracts of Cryptolepis sanguinolenta root were determined for 65 strains of Campylobacter jejuni, 41 strains of Campylobacter coli isolated from sporadic cases of gastroenteritis in Portugal and 86 strains of Vibrio cholerae isolated from patients with enteric infections in Angola, Brazil and Portugal. The ethanol extract activity against Campylobacter strains (MIC90% = 25 micrograms/ml) is higher than that of co-trimoxazole and sulfamethoxazole and Campylobacter strains susceptibility for cryptolepine (MIC90% = 12.5 micrograms/ml) is equal for ampicillin. The ethanol extract and cryptolepine show some activity against the Vibrio cholerae strains, although their activities are lower than that of tetracycline. The results suggest that these roots could be a therapeutic alternative for bacterial etiologic diarrhoea in West Africa.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7853867     DOI: 10.1016/0378-8741(94)90071-x

Source DB:  PubMed          Journal:  J Ethnopharmacol        ISSN: 0378-8741            Impact factor:   4.360


  8 in total

1.  Synthesis and evaluation of isosteres of N-methyl indolo[3,2-b]-quinoline (cryptolepine) as new antiinfective agents.

Authors:  Xue Y Zhu; Leroy G Mardenborough; Shouming Li; Abdul Khan; Wang Zhang; Pincheng Fan; Melissa Jacob; Shabana Khan; Larry Walker; Seth Y Ablordeppey
Journal:  Bioorg Med Chem       Date:  2006-11-01       Impact factor: 3.641

2.  Clinical efficacy of a tea-bag formulation of cryptolepis sanguinolenta root in the treatment of acute uncomplicated falciparum malaria.

Authors:  K A Bugyei; G L Boye; M E Addy
Journal:  Ghana Med J       Date:  2010-03

Review 3.  Indolo[3,2-b]quinolines: synthesis, biological evaluation and structure activity-relationships.

Authors:  Eyunni V K Suresh Kumar; Jagan R Etukala; Seth Y Ablordeppey
Journal:  Mini Rev Med Chem       Date:  2008-06       Impact factor: 3.862

4.  Antifertility activity of Cryptolepis sanguinolenta leaf ethanolic extract in male rats.

Authors:  Ayodeji F Ajayi; Roland E Akhigbe
Journal:  J Hum Reprod Sci       Date:  2012-01

5.  In vitro antimicrobial activity of ethanolic fractions of Cryptolepis sanguinolenta.

Authors:  Felix C Mills-Robertson; Samuel C K Tay; Goerge Duker-Eshun; Williams Walana; Kingsley Badu
Journal:  Ann Clin Microbiol Antimicrob       Date:  2012-06-18       Impact factor: 3.944

Review 6.  A Systematic Review of In Vitro Activity of Medicinal Plants from Sub-Saharan Africa against Campylobacter spp.

Authors:  Delfina Fernandes Hlashwayo; Filomena Barbosa; Sílvia Langa; Betuel Sigaúque; Custódio Gabriel Bila
Journal:  Evid Based Complement Alternat Med       Date:  2020-05-15       Impact factor: 2.629

7.  Cryptolepine inhibits hepatocellular carcinoma growth through inhibiting interleukin-6/STAT3 signalling.

Authors:  Seth A Domfeh; Patrick W Narkwa; Osbourne Quaye; Kwadwo A Kusi; Gordon A Awandare; Charles Ansah; Alimatu Salam; Mohamed Mutocheluh
Journal:  BMC Complement Med Ther       Date:  2021-06-02

8.  Alkaloids from Cryptolepis sanguinolenta as Potential Inhibitors of SARS-CoV-2 Viral Proteins: An In Silico Study.

Authors:  Lawrence Sheringham Borquaye; Edward Ntim Gasu; Gilbert Boadu Ampomah; Lois Kwane Kyei; Margaret Amerley Amarh; Caleb Nketia Mensah; Daniel Nartey; Michael Commodore; Abigail Kusiwaa Adomako; Philipina Acheampong; Jehoshaphat Oppong Mensah; David Batsa Mormor; Caleb Impraim Aboagye
Journal:  Biomed Res Int       Date:  2020-09-22       Impact factor: 3.411

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.